Kanagawa, Japan

Shin-Ichi Kitahara

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin-Ichi Kitahara. Retrieved from https://idiyas.com/inventor/shin-ichi-kitahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shin-Ichi Kitahara

Introduction

Shin-Ichi Kitahara is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic triazolobenzazepine derivatives. His research has led to advancements that may benefit various medical applications.

Latest Patents

Shin-Ichi Kitahara holds a patent for a novel crystalline compound, specifically a 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine. This patent, which is classified under 1 patent, also includes a pharmaceutical composition that incorporates this innovative compound.

Career Highlights

He is currently employed at Meiji Seika Kaisha, Ltd., where he continues to explore and develop new pharmaceutical solutions. His work is characterized by a commitment to enhancing drug efficacy and safety.

Collaborations

Shin-Ichi Kitahara collaborates with talented colleagues, including Sachiko Miyamoto and Yumiko Okada. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Shin-Ichi Kitahara's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors on medical advancements. His innovative work continues to pave the way for future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…